Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison Sells 25,000 Shares

Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

R Dirk Allison also recently made the following trade(s):

• On Monday, November 25th, R Dirk Allison sold 12,500 shares of Addus HomeCare stock. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock traded up $0.33 during midday trading on Friday, hitting $124.59. The company had a trading volume of 63,465 shares, compared to its average volume of 137,533. The stock has a market cap of $2.26 billion, a PE ratio of 28.51, a P/E/G ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.12. The business’s 50 day simple moving average is $125.19 and its two-hundred day simple moving average is $125.70.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter in the prior year, the business earned $1.03 earnings per share. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, sell-side analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Institutional Trading of Addus HomeCare

A number of institutional investors and hedge funds have recently modified their holdings of ADUS. Quarry LP acquired a new position in Addus HomeCare in the third quarter worth about $28,000. Quest Partners LLC bought a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $31,000. Farther Finance Advisors LLC grew its position in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the period. Sandia Investment Management LP acquired a new position in Addus HomeCare during the second quarter worth $58,000. Finally, GAMMA Investing LLC boosted its stake in shares of Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after purchasing an additional 191 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on ADUS. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. JMP Securities initiated coverage on Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price for the company. Oppenheimer increased their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of “Buy” and a consensus target price of $133.67.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.